1. Practitioner approval
We act only with the consent and direction of the appointed administrator, liquidator or responsible officer. Scope, buyer criteria and minimum terms are agreed in a written mandate before any outreach.
How it works
Each step is recorded so that the practitioner, buyers and their advisers can see what was done and why.
We act only with the consent and direction of the appointed administrator, liquidator or responsible officer. Scope, buyer criteria and minimum terms are agreed in a written mandate before any outreach.
We establish where each dataset came from, who owns it and what restrictions apply. That covers customer terms, privacy notices, licences, third-party content and contract limits. Datasets with unclear rights are excluded or referred for legal advice.
We remove or exclude personal information. Where data derived from individuals is in scope, our de-identification process follows the OAIC and CSIRO Data61 De-Identification Decision-Making Framework. We assess re-identification risk in the context the data will be released into. Sensitive and health information is out of scope.
We approach vetted buyers under NDA and share samples and documentation. We negotiate licence terms covering permitted use, a ban on re-identification and limits on onward transfer. The practitioner signs off before anything is executed.
Fees
We charge a success fee: a percentage of the net proceeds received by the estate, agreed in writing in the mandate before we start. There is no retainer and no upfront fee. If no transaction completes, there is no fee.
Third-party costs, such as independent legal or technical review, are only incurred with the practitioner’s prior written approval.